Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma.
Taylor JT, Ellison S, Pandele A, Wood S, Nathan E, Forte G, Parker H, Zindy E, Elvin M, Dickson A, Williams KJ, Karabatsou K, McCabe M, McBain C, Bigger BW.
Taylor JT, et al. Among authors: ellison s.
Neuro Oncol. 2020 Sep 29;22(9):1289-1301. doi: 10.1093/neuonc/noaa051.
Neuro Oncol. 2020.
PMID: 32227096
Free PMC article.